<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/72549</link>
    <description />
    <pubDate>Fri, 10 Apr 2026 10:48:52 GMT</pubDate>
    <dc:date>2026-04-10T10:48:52Z</dc:date>
    <item>
      <title>The Synapse : the Medical Professionals' Network : volume 19 : issue 4</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/72473</link>
      <description>Title: The Synapse : the Medical Professionals' Network : volume 19 : issue 4
Editors: Galea, Wilfred; Ellul, Ian C.
Abstract: Table of contents:; 1/ ELLUL, I. C. - "I am justly killed with mine own treachery"; 2/ COVID-19 R&amp;D fund; 3/ GRECH, A., &amp; BALZAN, M. - Brief overview of the applications of proteomics in theranostics; 4/ BELLIZZI, M. - The use of power words when dealing with chronic pain; 5/ ELLUL, I. C. - A Maltese medic in Copenhagen; 6/ VASSALLO, P. - Imaging back pain : part 1</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/72473</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>"I am justly killed with mine own treachery"</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/72373</link>
      <description>Title: "I am justly killed with mine own treachery"
Abstract: In the last editorial I referred to immunity passports and excess mortality measurements. I will discuss them briefly in relation to SARS-CoV-2.</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/72373</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>COVID-19 R&amp;D fund</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/72372</link>
      <description>Title: COVID-19 R&amp;D fund
Editors: Galea, Wilfred; Ellul, Ian C.
Abstract: At the beginning of April 2020, over 1 million active COVID-19 cases with over 59,000 deaths were reported. By early June 2020, cases soared to over 7 million with over 400,000 deaths affecting over 200 countries. Different trends were observed in different regions, with the situation stabilising in some, while still peaking in others. Due to the observed socio-economic impact, the European Commission (EC) adopted the Temporary Framework for State Aid Measures to Support the Economy in the Current COVID-19 Outbreak which enables Member States to administer State Aid funds. Through this framework the Maltese Ministry for Finance and Financial Services and the Ministry for the Economy, Investment and Small Businesses, took the opportunity to launch a national COVID-19 Research and Development (R&amp;D) Fund. [excerpt]</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/72372</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Brief overview of the applications of proteomics in theranostics</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/72371</link>
      <description>Title: Brief overview of the applications of proteomics in theranostics
Authors: Grech, Alfred; Balzan, Michael
Abstract: Theranostics is an emerging field of medicine that uniquely combines drugs and/or techniques to simultaneously or sequentially diagnose and treat medical conditions. Proteomics, the large-scale characterisation of proteins, is now being applied in theranostics. The proteome is the entire set of proteins that is produced by an organism. It varies temporally and spatially according to the distinct needs of the organism. Major breakthroughs in human proteomics are seen in its theranostics applications as biomarkers (e.g. in cancer, Alzheimer's disease, various other neurodegenerative disorders, autism, cardiovascular diseases) and in therapeutics (e.g. personalised treatment).</description>
      <pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/72371</guid>
      <dc:date>2020-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

